Download in electronic PDF format for $35

Search the Complete Journal Archives

Compounding with Controlled Substances

Author(s):  Whalen Mary Kate

Issue:  Jan/Feb 2002 - Compounding for Pain Management and Dental Medicine
View All Articles in Issue

Abstract:  The author, an attorney, provides an overview of the Controlled Substances Act and US Drug Enforcement Administration regulations regarding compounding and highlights recent issues regarding the use of controlled substances in formulations. She concludes that compounding pharmacists who compound controlled substances within the parameters for authorized compounding established by their state boards of pharmacy and US Food and Drug Administration guidelines should not have problems with their local Drug Enforcement Administration field office. However, if problems do arise, enforcement actions vary with each field office.

Related Keywords: Controlled substances DEA narcotic CSA FDA "Negative List"

Related Categories: BUSINESS, LEGAL

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Compounding with Controlled Substances Whalen Mary Kate Jan/Feb 2002 8-10 Buy
The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act Pore R David Nov/Dec 2012 446-450 Buy
The "Lists": What Do They Mean? Voliva John Nov/Dec 2016 477-479 Buy
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List) Nov/Dec 2016 457-458 Buy
Basics of Compounding: The "Negative" List Allen Loyd V Jul/Aug 2015 311-313 Buy
The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List") Allen Loyd V Jr, Ashworth Lisa D Jan/Feb 2005 44-46 Buy
Basics of Compounding: The Revised "Not to Compound List" Allen Loyd V Jr Jan/Feb 2015 57-58 Buy
Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Christiansen Joel, White Lyndell Jul/Aug 2010 310-314 Buy
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Blankenship Cynthia E Sep/Oct 2014 379-380 Buy
IACP's Continuing Support of Compounding Pharmacists: Letter to the FDA Concerning 503B Outsourcing Facilities Miller David G Mar/Apr 2014 117-118 Buy